Esperion

Esperion is a Michigan-based lipid management company that develops and commercializes oral therapies for the treatment of cardiovascular diseases.

Business Model:

Revenue: $72.1M

Employees: 201-500

Detailed Esperion Information

Esperion was acquired by Pfizer.
The acquisition happend on 2003-12-21.
Details of the transaction were not public

Acquirer

Geographic Data

Esperion headquarters map

Address: 3891 Ranchero Drive

City: Ann Arbor

State: MI

Zip: 48108

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$225M

Raised Total:

$481M

Metrics

1,628,915Website Global Rank

11,831Website Monthly Traffic

Twitter Followers

Description

Esperion is a Michigan-based lipid management company that develops and commercializes oral therapies for the treatment of cardiovascular diseases.

Contact Phone:
+17348873903

Contact Email:

Esperion went public on 7/5/2013 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
7/5/2013

IPO Valuation:
$196M

Ticker Symbol:
ESPR

IPO Price:
$14/share

Amount Raised:
$70M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research